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Data miningToday, advances in medical informatics brought on by the increasing availability of electronic medical
records (EMR) have allowed for the proliferation of data-centric tools, especially in the context of person-
alized healthcare. While these tools have the potential to greatly improve the quality of patient care, the
effective utilization of their techniques within clinical practice may encounter two signiﬁcant challenges.
First, the increasing amount of electronic data generated by clinical processes can impose scalability chal-
lenges for current computational tools, requiring parallel or distributed implementations of such tools to
scale. Secondly, as technology becomes increasingly intertwined in clinical workﬂows these tools must
not only operate efﬁciently, but also in an interpretable manner. Failure to identity areas of uncertainty
or provide appropriate context creates a potentially complex situation for both physicians and patients.
This paper will present a case study investigating the issues associated with ﬁrst scaling a disease predic-
tion algorithm to accommodate dataset sizes expected in large medical practices. It will then provide an
analysis on the diagnoses predictions, attempting to provide contextual information to convey the cer-
tainty of the results to a physician. Finally it will investigate latent demographic features of the patient’s
themselves, which may have an impact on the accuracy of the diagnosis predictions.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Over the past decade the digitization of healthcare records has
provided a foundation for data scientists and clinicians alike to
employ data mining and machine learning techniques on medical
datasets [1]. These techniques have allowed for not only substan-
tial improvements to existing clinical decision support systems,
but also a platform for improved patient-centered outcomes
through the development of personalized prediction models tai-
lored to a patient’s medical history and current condition [2–5].
While powerful, the integration of such tools into clinical work-
ﬂows is a challenging endeavor. This paper will address two major
components integral for the successful integration of analytical
tools into a clinical workﬂow.
Of ﬁrst concern is incorporating these tools within a clinical
time frame and context. Due to the time sensitive nature of clinical
scenarios, the machine learning models on which these tools are
built must allow for execution within a relevant timeframe, which
is often only the duration of a patient visit. As the data becomesincreasingly available, drawn from multiple sources and encom-
passes multiple modalities, it also becomes critical for machine
learning methods to process them both accurately and quickly. If
a patient’s current visit is used during a physician’s ofﬁce visit to
suggest a series of personalized recommendations, then it is
warranted that the back-end prediction engine is able to deliver
within this timeframe. However the quantity of data necessary to
build these models presents a signiﬁcant issue for successful
long-term utilization. It is important to remember that each
medical encounter will result in additional data added to a
patient’s electronic health record.
Although for now this limitation can be overcome with algo-
rithmic ingenuity, healthcare’s ‘‘Big Data’’ may soon exceed the
ability of standard data processing techniques, given its variety,
veracity and volume. As a result we must look to other approaches,
such as distributed computation, in order to scale personalized
healthcare models. Failure to do so may result in the need to arti-
ﬁcially restrict the data on which the models are built. This would
typically be accomplished either through the process of feature or
instance selection, the difﬁculties of which have already been well
documented [6–8].
The ability to utilize these tools within a constrained time win-
dow is not the only obstacle to their deployment in clinical
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the implementation of predictive models, patients are no longer
the only individuals receiving treatment recommendations.
Physicians will now begin to receive treatment recommendations
personalized to their current patient. Although these tools and
techniques are designed to augment the existing skills of the physi-
cian, expanding their clinical knowledge beyond their prior experi-
ence and education, they also introduce a new challenge of
providing an appropriate narrative with the predictions or the
analytics.
It is important to remember that while these predictions may
be the result of advanced machine learning models, they have to
be assessed and communicated within a clinical context. While
physicians will likely be equipped to understand the clinical
aspects of the recommendations they receive, as well as the risks
associated with them, there is currently no process in place to
ensure the algorithmic results are clinically interpretable. To date
a substantial set of prior work has been done tuning the perfor-
mance of these algorithms, and although these evaluations help
to create functional and effective models, many fail to perform
any medically focused evaluation of the predicted instances [9,10].
However due to the complexities of human disease, and the
uniqueness of each patient, a deeper understanding of the algo-
rithm producing the recommendation is critical for the successful
integration of these tools into a clinical workﬂow. As an example
the high probability of a frequently misdiagnosed disease may
not be as diagnostically useful for a physician as would a slightly
lower probability disease, that when predicted is almost always
correct.
This paper will provide a case study addressing each of the inte-
gration challenges discussed above, walking through the process of
bringing a disease prediction algorithm out of an academic setting
and preparing it for the complexities of a clinical setting. For the
study we will be utilizing the disease prediction algorithm CARE
(Collaborative Assessment and Recommendation Engine) [11].
We have chosen CARE as the algorithm has already been shown
to be effective, and as we will see CARE is a good proxy for an entire
class of disease prediction algorithm utilizing patient similarity
techniques. The scaling of CARE using distributed computing con-
structs can thus provide a possible template for integration with
other existing disease prediction algorithms that leverage
large-scale electronic health care records. Finally, as we will see
throughout this paper, it is important to contextualize the outcome
of any clinical decision making aid for patient as well as physician
consumption in order to reach the goal of ‘‘patient empowerment
and engagement’’.
The paper is structured as follows. We will begin with a back-
end system-level investigation into the task of scaling the CARE
algorithm to accommodate the patient datasets representative of
true clinical databases. Next we include an in-depth analysis of
the CARE algorithm from a clinical perspective, identifying those
diagnoses that CARE can frequently predict correctly, and those
that may present difﬁculty, and how these insights may translate
to the patient. It will then evaluate patient demographic data, iden-
tifying latent features which may indicate the difﬁculty of correctly
predicting an individual’s future diseases as well the distribution of
diagnosis across the highest and lowest performing individuals.2. Disease prediction algorithm
Over recent years a number of disease prediction algorithms
have been developed to accomplish a multitude of tasks. While
some algorithms focus on modeling an individual’s risk of develop-
ing speciﬁc diagnoses such as cardiac conditions, others can be uti-
lized in a more general approach to identify individuals’ high-riskfuture conditions [5,12–14]. The past few years have witnessed
further development of these predictive tasks, creating systems
to model tasks such as the progression of degenerative diseases
as well as extensions into the genomic ﬁeld, identifying target sites
utilized in biomarker and drug discovery [15–17].
2.1. The CARE algorithm
Amongst the earliest general disease prediction models for per-
sonalized healthcare that leverage patient similarity is the CARE
Algorithm. CARE uses collaborative ﬁltering of an individual’s med-
ical history in order to identify high likelihood diagnoses in the
patient’s future. Collaborative ﬁltering is traditionally a technique
by which similar individuals are identiﬁed through a set of known
shared preferences or attributes. The intent of collaborative ﬁlter-
ing is to identify new preferences for an individual based on the
non-shared preferences identiﬁed between other similar individu-
als [18–20]. While these techniques have been utilized for many
years in online applications such as movie, book and product rec-
ommendations, they have recently shown promise in the health-
care domain as well. Beyond CARE, a number of recent
algorithms have utilized collaborative ﬁltering for applications
such as nursing decision support, medical context identiﬁcation,
and identiﬁcation of sudden deterioration for a patient’s medical
condition [21–23].
An architectural diagram of the standard CARE algorithm can be
seen in Fig. 1 [11] and is comprised of three major steps. For a
patient p, the algorithm begins with an initial ﬁltering on all
patients within the database, isolating only those patients who
have at least one disease in common with p. This is done as totally
disparate patients offer no potential similarity information, and
will only serve to extend the computation time. Next utilizing this
subset of patients the collaborative ﬁltering step is performed.
CARE’s collaborative ﬁltering algorithm incorporates a binary cod-
ing of diagnoses codes, with 1 representing a present diagnosis,
and 0 one which is absent or undiagnosed. In addition, the inverse
frequency of each diagnosis is used in order to give higher weight
to less common diagnosis. This is particularly important as some
diagnosis, such as hypertension, are present in 33.64% of all
patients [11]. CARE also incorporates a time component represent-
ing when in the patient’s medical history did they develop a dis-
ease. Next, an ensemble of such collaborative ﬁltering models is
generated for each similar set of patients identiﬁed for each disease
of p. Finally the results are then aggregated, yielding a ranked list
of high probability diseases for p.3. Materials and methods
As mentioned prior the CARE algorithm has been previously
shown to be accurate, and in an effort to maintain consistency with
the published work the original dataset and source code were used
in this case study as in the original CARE evaluation.
3.1. Data
The dataset utilized for this work contains approximately 32
million anonymized Medicare claims each representing a patient
visit, accounting for just over 13 million unique patients. As per
the original CARE work, in order to ensure sufﬁcient diagnosis his-
tory during training only those patients with over 5 visits were
considered for evaluation in this paper [11].
TheMedicare claim itself contains 16 features aswell as a unique
identiﬁer for patients with multiple visits. The claim is broken into
two main sections, patient demographics and diagnosis codes.
Patient demographics contains the date of the visit, the patient’s
Fig. 1. Current CARE implementation [24].
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ables. These anonymous variables include the patient’s race, geo-
graphic state code, as well as gender and poverty ﬂags. The
diagnosis codes section of the claim contains 1 primary, and up to
9 secondary diagnosis codes for each patients visit. All diagnoses
codes are represented by the International Classiﬁcation of
Diseases, Ninth Revision, Clinical Modiﬁcation (ICD-9-CM) [25].
One feature that requires further exposition is Age. As stated
above the patients in the dataset must have at least 5 visits, which
may span multiple years. As such, we decided to use their age at
the time of their ﬁrst recorded Medicare claim. This decision is
supported by the unfortunate reality that the likelihood of health
complications increases as an individual ages. Thus, synthetic age
metrics such as a patient’s mean and median claim age may be
artiﬁcially right-skewed by the increasing frequency of claims at
increasing ages. Further, the age of their ﬁrst Medicare claim
may be indicative of the early onset of health complications.
Finally, it is important to note the concept of code collapse as it
relates to the hierarchical nature of ICD-9 diagnosis codes. A com-
plete ICD-9 code is typically 5 digits in length, with the leading dig-
its representing the medical diagnosis family, while the trailing
offer speciﬁcs about the condition such as the location or severity.
As a result these codes can be collapsed into more general repre-
sentations. Three digit codes are known as the ‘‘Major Category’’,
four digit as ‘‘Intermediate Category’’ and ﬁve digit codes as the
‘‘Minor Category’’ representing the level of speciﬁcity detailed at
each level [26]. Multiple code collapse levels from 5 digits, to 4,
to 3 digits will be used within the disease evaluation portion of this
paper, while the patient evaluation will utilize the fully detailed
5-digit code.
3.2. Algorithmic procedure
The analyses required for the case study are broken down into
two main components. First we address the scaling issue,performing an exploration of execution bottlenecks and develop-
ing a scalable distributed implementation of the CARE algorithm,
which can be extended to any frameworks that compute patient
similarity. Secondly we detail the strengths and weaknesses of
the algorithm in terms of speciﬁc diagnosis codes as well as demo-
graphic attributes of the patients themselves. The major contribu-
tion for each of these analyses will be denoted within the section
headers ‘‘Scaling’’ and ‘‘Contextualizing’’ respectively.3.3. Scaling CARE
Through a detailed analysis of the CARE algorithm we were able
to identify parallelizable components within the patient similarity
process, greatly reducing the execution time required to obtain the
disease rankings. We will demonstrate the ability to scale CARE’s
usage on Big Data to achieve execution times at approximately
one sixth of a day. We will also examine the implications of execu-
tion time when accounting for the limited duration of a typical
clinical encounter.3.3.1. Evaluation metrics and environment
As the scaling analysis is at its core a systems level analysis, it is
important to ﬁrst deﬁne the metrics and computing environment
used to evaluate the CARE algorithm. For our evaluation we utilize
two primary metrics, total execution time, and the total number of
patients on which the algorithm is trained. As noted prior, due to
the time sensitive nature of clinical environments the execution
time of the algorithm is a critical component for the successful
integration of informatics tools into a clinical workﬂow, and as
such total execution time will be utilized as the principle evalua-
tion metric. Further, as a result of the collaborative ﬁltering per-
formed as part of the CARE algorithm the total number of
patients on which the algorithm is trained is also an important
statistic. As demonstrated empirically by Breese et al. the size of
380 K. Feldman et al. / Journal of Biomedical Informatics 57 (2015) 377–385the training set is directly related to the accuracy of collaborative
ﬁltering algorithms [20].
To benchmark the standard CARE algorithm we utilized a
machine containing 4, 16-core 2.3 GHz AMD Opteron processors
with 128 GB RAM. All simulations were run 5 times, and the results
averaged to obtain the reported performance statistics.
Additionally, prior to each benchmark CARE was executed in a sin-
gle non-timed run to warm the cache with the respective patient
and disease records. Finally, CARE was compiled with the -O0 ﬂag
to disable any architecture speciﬁc complier optimizations. While
this may cause a slight increase in overall execution time, the per-
formance will be signiﬁcantly more stable between multiple
machines; a particularly important element for the distributed ver-
sion detailed below.
It should be noted that due to the variability in execution time
all evaluations were performed with at least 25 patients. This is a
reasonable requirement, as even the smallest medical practices
can be expected to have medical records for 25 unique patients.
3.3.2. Identifying scaling opportunities in CARE
Our ﬁrst step was to perform a sweep of CARE over an increas-
ing number of patients, analyzing the time spent within each inter-
nal function. As CARE utilizes collaborative ﬁltering, it was logical
to see the all-pairs similarity comparison identiﬁed as the primary
bottleneck. From here we then investigated the individual compo-
nents, which comprise this portion of the algorithm, identifying
three main opportunities: the time needed to aggregate the diag-
noses codes from each patient’s visit set (visit aggregation); the
similarity calculation between the diagnosis vectors of two
patients (vector similarity); and the system calls used to perform
the computation (system computation).
3.3.3. Distributed analysis
Using the execution statistics obtained from the standard CARE
execution we then created a distributed version of the algorithm,
the goal of which was to perform within a reasonable clinical time-
frame as well as increase the size of the patient training set.Fig. 2. Distributed CARAlthough all patients’ medical histories are required to train a
complete model, each patient’s disease similarity is calculated
independently, providing an ideal scenario for parallelization.
First the set of all patients is partitioned into equal size subsets,
and then using the WorkQueue algorithm created by the
Cooperative Computing Lab (CCL) at Notre Dame, we distribute
the execution across a compute grid [27]. This process is detailed
in Fig. 2.
However, while parallelization is an effective method of scaling
these algorithms, due to the highly sensitive nature of healthcare
data the distribution of data can provide a challenge. Prior work
Berkvosky el. in [28] has evaluated the issue of privacy when using
collaborative ﬁltering techniques on distributed data sets. In their
implementation, Berkvosky details a method where each calcula-
tion’s subset of data contains only a minimal amount of identiﬁ-
able information. However, we aim to take the method one step
further and distribute the computation to each data site, where
each worker receives a copy of the CARE algorithm as well as infor-
mation about the subset it is tasked to compute. Further, the work-
queue framework allows for access to a centrally located set of
patient records though a shared ﬁle system. This setup would
address privacy concerns as only result of the similarity calcula-
tions are then transmitted over the network, a process more akin
to the MapReduce framework [29].3.4. Contextualizing CARE
Once we had established that the CARE algorithm could be aug-
mented to execute on realistically sized datasets, we looked to the
second integration challenge of generating context around the
diagnosis predictions. This analysis explores two main aspects of
this interpretability, pertaining to the patient’s diagnosis rankings,
and the demographics of the patient themselves. An example of the
contextualization workﬂow can be found in Fig. 3. The workﬂow
begins with the probabilistic ranked list of diagnosis predictions
provided by the CARE algorithm. Next through the analyses tech-
niques found within this paper we provide contextual informationE implementation.
Fig. 3. Contextualization workﬂow.
Fig. 4. Example CARE ranking.
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sonalized demographic data, as well as conﬁdence based on the
speciﬁc diagnosis codes predicted. As noted earlier this diagnosis
code level analysis is pertinent as the identiﬁcation of speciﬁc diag-
nosis codes that when found on the ranked predicted list, are
almost always correct would be extremely useful for a physician
to know when planning their course of action, despite being
ranked somewhat lower than expected. Finally these analyses lead
back into physician’s interpretation of the results, as our goal
remains to provide tools to better inform their clinical decisions
not make them autonomously. We then provide a compelling case
study into how a physician may identify a patient at risk for pros-
tate cancer by utilizing both their prior clinical knowledge, and a
contextual understanding of the algorithm’s high conﬁdence diag-
noses. Finally we demonstrate that difﬁcult to predict patients may
in fact have a statically different demographic proﬁle from those in
the general population.3.4.1. Diagnosis analysis
The goal of the diagnosis analysis was to provide a physician
with insight into the various codes recommended for each patient.
Since CARE creates personalized diagnosis predictions for each
patient, we designed a metric order to objectively evaluate the
overall predictability of each diagnosis code. The evaluation was
performed for each disease d, with each patient p treated as an
instance. The predictability metric utilizes both the diagnosis code
ranking from p’s CARE prediction, as well as an associated class
variable to indicate the correctness of the prediction (1 if the diag-
nosis truly occurs in p’s future, 0 if it does not). If the current code
was not present on the ranked list of diagnoses produced by CARE
for patient p it receives a value of1. It is important to note that the
instance p is removed for a particular d if that diagnosis occurs
both in the patient’s history as well as their future diagnosis.
This is to help prevent any potential bias in the resulting pre-
dictability score for diagnosis such as chronic conditions that
may occur many times though a patient’s medical history, and thus
would be easily predicted artiﬁcially increasing the algorithms
accuracy.
Using the augmented dataset containing diagnosis codes and
correctness, the precision and recall are calculated over a threshold
of 1–50. The predictability score of d is then computed as the area
under the precision-recall curve (AUPR). A toy example of this pro-
cess over the top 5 ranks is provided in Fig. 4. Finally it is important
to note, that while some diagnosis may always be associated with a
single ICD-9 code, others may be distributed across multiple
5-digit codes based on slight variations in diagnosis details. Toaccount for these potential variations we perform the same analy-
sis across 5, 4 and 3-digit ICD-9 code groupings.3.4.2. Patient analysis
The goal of the patient analysis was to identify demographic
characteristics at the patient level that inﬂuence CARE’s overall
predictive success. Insights such as these would prove invaluable
to a physician attempting to identify a patient for whom external
factors such as age or race may inﬂuence the models predicted
conditions. As with the diagnosis predictability, we created a met-
ric to quantify the predictability of a particular patient. Since each
patient has a unique set and number of diagnoses we decided to
utilize the Jaccard coefﬁcient set similarity metric for the pre-
dictability score [30]. The Jaccard coefﬁcient is calculated as fol-
lows JðA;BÞ ¼ jA\BjjA[Bj, where we can deﬁne our sets with respect to
an individual patient p. Set A is deﬁned as the set of diagnoses
CARE correctly predicts across all visits for p, and set B is deﬁned
as the set of all diagnoses recorded across all visits for p. The
Jaccard coefﬁcient then results in a standardized metric of the
overall effectiveness of CARE’s diagnosis predictions with respect
to an individual patient.
It should also be noted that precision was not included as factor
in the patient’s predictability score. This is due to the fact that the
absence of a diagnosis in claims data cannot be viewed as a conﬁr-
mation to the lack of that particular the diagnosis for a patient. For
clarity the absence of a diagnosis in claims data fails to differenti-
ate a patient who will receive that diagnosis after the data collec-
tion period was ﬁnished (a correct future prediction outside of the
study window), a patient who was not diagnosed despite having
the condition, or those who truly never had the condition. Thus
the coverage of that patient’s future diagnosis set becomes more
important than the total number of diagnoses that do not occur.
For the patient analysis the CARE algorithm was trained across
all visits for 10,000 unique patients, and evaluated on a separate
10,000 patient set. Predictability scores were then calculated for
each of the test patients as detailed prior. Using these scores those
patients with the top 10% were classiﬁed as high performers, while
those with the bottom 10% were classiﬁed as low performers.
These high performer and low performer groups form the popula-
tions for an additional diagnosis evaluation, the goal of which is to
identify frequent diagnosis subgroups indicative of a high/low per-
forming patient.
In order to identify the demographic features that impact
CARE’s diagnosis prediction coverage for a patient, we evaluated
the distribution of each of the 5 demographic features age, race,
geographic state code, gender, and poverty level ﬂag using a
Chi-Squared goodness of ﬁt test.
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from the full patient population, and the sample distributions
drawn from the high and low performing patient groups. TheTable 1
Avg total runtime per task of distributed CARE.
Task count Avg IO overhead (s) Avg. CPU time (s)
10000 0.017 134.358
25000 0.021 43.811
50000 0.098 19.412
100000 0.101 6.658
Table 2
Top 5 most predictable codes.
3-Digit codes 4-Digit codes
Top 5 most predictable codes
401 Hypertension 2826 Sickle-cell disease
272 Disorders of lipoid metabolism 4019 Unspec. Essential
250 Diabetes 2500 Diabetes w/out co
786 Symptoms resp. system 6000 Hypertrophy of pr
780 General symptoms 7194 Pain in joint
Table 3
Top 5 least predictable codes.
3-Digit codes 4-Digit codes
Top 5 least predictable codes
553 Hernia of abdominal cavity 7886 Abnorma
389 Hearing loss 5246 TMJ diso
560 Intestinal obstruction w/out hernia 3899 Unspec.
536 Disorders of stomach function 5368 Dyspeps
410 Acute myocardial infarction 6010 Acute prChi-Squared statistic was computed using K-1 degrees of freedom,
where K is the number of levels of each demographic variable. In
the case of the continuous variable Age the data was discretized
into 7 bins each spanning 5 years, with the ﬁnal bin pooled all ages
over 95.4. Results
4.1. Scaling CARE
The execution timing results for the unmodiﬁed CARE algorithm
can be found in Fig. 5. As noted above, while trivial, we isolated the
I/O and CPU bound elements of the algorithm noting that CARE
spent 93% of it’s execution time in CPU based components for data-
sets containing as low as 250 patients. From here we found that
CARE spent greater than 99% of all CPU time in a single function,
known as best match, which executed the collaborative ﬁltering
operations. Breaking down the Best Match function further we
found that although the execution time was exponential (Fig. 5),
the percent of time spent in each of these step of the function
remained fairly steady over increasing numbers of patients. With
the vector similarity, visit aggregation, and system computation com-
prising approximately 42, 8, and 50 percent of the total execution
time respectively, with an average standard deviation of 1.61%. The
results of the distributed version of CARE can be found in Fig. 6,
with more detailed statistics on the WorkQueue workers
performance found in Table 1.4.2. Contextualizing diagnosis analysis
Tables 2 and 3 detail CARE’s top 5 most and least predictable
diagnosis codes respectively, with the rankings calculated for each
of the three code collapse levels (5,4 and 3 digits ICD-9 codes). ForNum. worker cycles Derived execution time (h)
200 7.465
500 6.088
1000 5.419
2000 3.755
5-Digit codes
25002 Diabetes w/out complication uncontrolled
hypertension 60001 Hypertrophy of prostate w/ obstruction
mplication 60000 Hypertrophy of prostate w/out obstruction
ostate 60010 Nodular prostate w/out obstruction
25000 Diabetes w/out complication controlled
5-Digit codes
lity of urination 72887 Muscle weakness
rders 78909 Abdominal pain other speciﬁed site
hearing loss 78863 Urgency of urination
ia 68110 Cellulitis/abscess of toe
ostatitis 80700 Closed fracture of rib(s)
Table 4
Chi-Squared results.
High performing patients
Chi-Squared p-value
Demographic
feature
Low performing patients
Chi-Squared p-value
.16 Age 4:40e3 
.42 Gender .11
.38/.42 Race 1:36e6=2:41e7 
2:67e7  Poverty line
ﬂag
1:06e7 
3:90e3=5:74e3  Geographic
state
7:64e4=1:81e3 
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which receive the highest AUPR values. However, the least pre-
dictable diagnoses are calculated slightly differently. Due to the
number of unique diagnoses (5,949) it is likely that not every dis-
ease is represented within each test set. As AUPR is bounded in the
range [0,1], this creates the situation where many diagnoses may
occur with low AUPR values and minimal variation, making differ-
entiation difﬁcult. To account for this we utilize the concept of
diagnosis prevalence to the calculation of the least predictable
rankings. The least predictable diagnoses are then calculated utiliz-
ing the count of patient instances p that actually receive the future
diagnosis d, despite never having d receive a ranking in the CARE
results.4.3. Contextualizing patient demographic analysis
As detailed in the Methods section the patient analysis was bro-
ken down into high performer and low performer groups, contain-
ing 1335 and 1179 patients respectively. Both patient groups are of
sufﬁcient sample size, where the resulting Chi-Squared p-value has
been shown to become essentially equivalent to that of the Fisher’s
exact test [31].
The results for the signiﬁcance tests on both groups can be seen
in Table 4, with signiﬁcant (p<0.05) values indicated with an aster-
isk. Two features, Race and Geographic State, have additional
p-values recorded, as these features contained distributions which
resulted in expected values less than 5. As this is a requirement forTable 5
High performing patient top diagnosis.
Top 5 overall diagnosis Top 5 unique diagn
Code Description Code
4280 Unspec. congestive heart failure 5723
4140 Coronary atherosclerosis 1622
496 Chronic airway obstruction 3942
4019 Unspec. hypertension 2532
4111 Intermediate coronary syndrome 45621
Table 6
Low performing patient top diagnosis.
Top 5 overall diagnosis Top 5 uniq
Code Description Code
4019 Unspec. hypertension 1530
496 Chronic airway obstruction 45111
5990 Unspec. site urinary tract infection 3014
4280 Unspec. congestive heart failure 44621
4140 Coronary atherosclerosis 220the Chi-Squared test, those levels with expected values fewer than
5 were pooled into a new Other category and the Chi-Squared
statistic recalculated. The format for these features is as follows:
unmodiﬁed distribution/pooled distribution.
Continuing with the patient analysis, we investigated the preva-
lence of diagnosis across both the high and low groups. The top 5
most prevalent diagnoses for each can be seen in the leftmost col-
umns in Tables 5 and 6 respectively. As high prevalence diagnoses
are likely to bias the top 5 rankings regardless of performance
group, we extended the analysis to examine the top 5 diagnosis
codes which are unique to each performance group. These results
can be found in the rightmost columns of Tables 5 and 6.
As a point of reference the high performers contained 2084 dif-
ferent diagnosis codes, compared to the 2401 of the low perform-
ers. The groups shared 1558 codes, leaving the high and low
performing groups with 526 and 843 unique diagnosis codes
respectively.5. Discussion
5.1. Scaling CARE in a distributed fashion
The beneﬁt of the distributed CARE algorithm can best be con-
veyed with an example. Utilizing the execution times of the stan-
dard version of CARE we were able to ﬁt the results with the
exponential function 60:3882e0:00073x. Please note that there are
opportunities to further optimize this code itself, but we wanted
to use the exact codebase as used in the original paper for consis-
tency. However, gains achieved from this scaling will be reﬂected
in both the sequential and distributed version, so using the original
codebase was sufﬁcient for this paper. From this curve we can
expect a dataset of 100,000 patients, a total patient size easily
obtained and eclipsed by larger medical practice or hospitals, to
take approximately 7:04e25 years. However, looking at the dis-
tributed CARE’s execution time on the same set of 100,000
patients, we see a runtime of approximately 4 h. This could be uti-
lized in one of two ways. First the algorithm could be utilized to
preprocess the data within a full clinical dataset each night for
the existing patient records, and presented to the physician perosis
Description
Portal hypertension
Malignant neoplasm of main bronchus
Mitral stenosis w/insufﬁciency
Panhypopituitarism
Esophageal varices in diseases classiﬁed elsewhere w/out mention of bleeding
ue diagnosis
Description
Malignant neoplasm of hepatic ﬂexure
Phlebitis and thrombophlebitis of femoral vein (Deep) (Superﬁcial)
Obsessive–compulsive personality disorder
Goodpastures syndrome
Benign neoplasm of ovary
Table 7
Avg IO overhead for patient dataset in ls.
Task count 1000 10,000 25,000 50,000
Patients per task 50 5 2 1
No cache 43618.23 43609.78 46276.27 57924.65
Cache ﬁrst access 58597.37 50521.59 57008.15 54396.94
Cache subsequent access 29.92 32.11 29.89 31.43
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patient the algorithm could be run on a 4000 patient subset in
around 23 s. To contrast unmodiﬁed CARE takes approximately
17 min to process the same 4000 patient dataset. While this may
not seem to be an exorbitant amount of time, the issue comes
clearer when presented with the fact that prior studies have shown
an entire clinical encounter lasts around 17 min [32]. A total time
that includes ancillary activities such as recording a patient’s vital
signs, thus our distributed version leaves signiﬁcantly more time
for the physician to review and interpret the results.
As our overarching goal was clinical integration we also aimed
to demonstrate that this complexity could be further reduced. We
investigated the beneﬁts of caching input ﬁles, such as the CARE
algorithm and patient data, on each of the worker machines the
results of which can be seen in Table 7. As you can see, the cache
access effectively alleviates the majority of the system overhead.
Although there may be a diminishing beneﬁt with increasing num-
ber of workers we were not able to reach a point at which commu-
nication overhead affected overall execution time, even on the full
5-visit patient dataset. This supports the idea that regardless of the
system setup a medical provider could simply utilize the full set of
computational resources available without the need for complex
optimizations.
5.2. Contextualizing diagnosis analysis
The evaluation of diagnosis predictability yielded two distinct
sets for interpretation. Beginning with the most predictable diag-
noses, we ﬁnd they fall predominantly into two main categories.
The ﬁrst category contained diagnoses common with elderly
patients, such as hypertension, diabetes and osteoporosis. This is
logical, as the minimum age for patients in the Medicare data
was 65, with a mean and median of 76.83 and 76 respectively.
The second category contained common co-morbid diagnoses such
as fatigue and joint pain, as well as respiratory conditions and sec-
ondary infections, such as bronchitis and sinusitis, which often
develop as a result of other illnesses.
Overall the high performing diagnoses seem promising, identi-
fying frequently co-morbid conditions. However, transitioning
these predictions to actionable insight for a physician remains a
critical step for successful integration into a clinical workﬂow. An
example of how this insight may be accomplished can be illus-
trated with an example scenario. Looking at the results of the
5-digit most predictable codes we see the code 60010. 60010 rep-
resents nodular prostate without urinary obstruction, which falls
under the diagnosis category Hyperplasia of prostate. It has been
shown that most prostate cancer (PCA) arise concomitantly with
nodular hyperplasia [33]. The high performance of this diagnosis
provides an ideal example of where a physician aware of both
the medical implications of a diagnosis and the strengths of the
prediction algorithm may be alerted to a promising avenue for
investigation, furthering the goal of providing of preventative med-
icine to a potentially at risk patient.
The least predictable diagnoses can also be separated into two
clear groups, injuries and infections. The difﬁculty encountered
in predicting these diagnoses is logical as the prediction of injuries
such as hernia and fractures would prove to be nearly impossiblebased solely on a patient’s medical history without a physical eval-
uation. This further highlights the need to make the physician
aware of the limitations of the algorithm producing the recom-
mendations. As an example high risk conditions, such as internal
bleeding, may be ranked lower for a patient suffering from trauma
after an accident due to algorithmic afﬁnities.
There was however one anomaly in the least predicted set,
myocardial infarction was amongst the top 10 in both the 3-digit
code 410 and the 4-digit 4109 (ranked 6th and not shown in
Table 3). We believe that while there are many warning signs for
myocardial infarctions, such as obesity, tobacco use and high
cholesterol, which should be identiﬁed by CARE, but the availabil-
ity of such data itself presents an issue. Although the conditions
that precede a myocardial infarction are well documented, they
are not well reported. Non-acute risk factors such as the observa-
tion of obesity or tobacco use are often not documented in a
patient’s medical record. This is reﬂected in our dataset, as the
prevalence of documented obesity is clearly under-reported at
1.3%. As a point of reference the Centers for Disease Control and
Prevention (CDC) collected obesity prevalence data in same region,
during the same time period that our dataset was being compiled.
Their estimated rate of obesity fell somewhere between 26.3% and
29.7% [34]. This highlights another important point, that the pre-
dictions produced by any algorithm can only be as good as the data
being utilized to make them.
5.3. Contextualizing patient demographic analysis
Prior to detailing the results of the patient analysis it is impor-
tant to note that in good faith with the data sharing agreement the
authors have not attempted to discern the underlying values of any
anonymized demographic feature. As such the analysis focuses on
the identiﬁcation of which demographic features are indicative of a
patient’s predictability.
5.3.1. Demographic proﬁle
Once we had identiﬁed the high and low performer group, we
were able to perform a detailed analysis of the demographic proﬁle
of associated with each group.
High performing individuals follow a fairly similar demographic
proﬁle to the overall Medicare population, with the exception of
states codes and the poverty line ﬂag. As the state codes are anon-
ymized we cannot comment on how geographic location of a
patient affects the predictability of diagnosis. However the pres-
ence of both geographic location and poverty as signiﬁcant fea-
tures provides evidence that socioeconomic condition may not
only be indicative of an individual’s overall health, but potentially
of precisely which health conditions they may be at risk for.
On the other hand low performing individuals had a largely dif-
ferent overall demographic proﬁle; having signiﬁcantly different
distributions in 4 of the 5 demographic features, with the excep-
tion of gender. Again we ﬁnd poverty-line ﬂag and geographic state
code as signiﬁcant features, likely due to the same reasons dis-
cussed above.
Looking further we note that the age distribution is signiﬁcantly
different than the standard Medicare population within the low
performer group, elevated from the baseline population expected
value in 3 of the 4, 5-year age bins age ranging from 65 to 80.
This lends credence to the idea that early onset diagnosis may pro-
duce more difﬁcult diagnosis patterns over course of a patient’s
lifetime.
5.3.2. Performance group diagnosis
After completing the demographic proﬁle analysis we then
moved into an investigation into the diagnosis subgroups present
within each performance category, and how they could be utilized
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diagnoses of hypertension and atherosclerosis appear in the top
5 of both performance groups as they are the top 2 most prevalent
diagnosis reported in 33.64 and 21.16 percent of all patients
respectively [11].
However it is the unique diagnosis codes that offer some
interesting insights into the differentiation of these groups.
The high performer patient group contains the diagnosis
panhypopituitarism (2532), which is a form of hypopituitarism.
Panhypopituitarism is a typically lifelong condition where the
pituitary gland does not produce normal amounts of some or all
of its hormones [35]. It is interesting that lifelong conditions occur
frequently amongst those patients on which CARE performs well.
Although these diagnoses may not be among the most prevalent
or predictable, they likely have well deﬁned co-morbid diagnoses.
Thus a well-informed physician may make use of their appearance
in a patient’s algorithmic predictions as a signal to screen for
known co-morbid conditions.
On the other end the top 5 unique diagnoses for the low per-
former patients also present some intriguing codes, such as
Goodpastures Syndrome. Goodpastures Syndrome is a rare autoim-
mune disorder, which has a particularly quick onset [36]. The
National Library of Medicine notes that symptoms may occur very
slowly over months or even years. This extended time frame, along
with the generic nature of the symptoms makes early of this
diagnosis extremely difﬁcult.6. Conclusion
This paper provides an extensive discussion of the integration
challenges for informatics tools into clinical workﬂows. The case
study of the CARE algorithm has provided an informative look at
how these tools can be effectively utilized to provide both a com-
putational and diagnostic advantage to clinicians utilizing them.
We have demonstrated how the rate at which healthcare data is
growing will soon necessitate the ability to scale these tools to
maintain their effectiveness and accuracy outside of an academic
setting. Further we provided two compelling scenarios in which
an understanding of the algorithms’ strengths along with a clinical
understanding of the conditions predicted could be used to
improve patient care; either by preventative prostate cancer test-
ing or early identiﬁcation of co-morbid conditions lifelong condi-
tions such as panhypopituitarism. Additionally, we have shown
that predictive performance is not only a byproduct of the algo-
rithm itself, but may also be linked the demographic proﬁle of
the individuals whose diagnosis are being predicted.
Finally it is important to remember that regardless of the diag-
nostic tools used; ultimately a patient’s treatment course will be
decided by their physician. As such, we hope this paper has con-
veyed the importance of creating tools that scale and are clinically
interpretable to serve as a decision aid or assistant for physicians.Conﬂict of interest
The CARE IP (Patent No. 8,504,343) has been licensed to
iCareAnalytics, LLC by the University of Notre Dame. Nitesh
Chawla serves as a scientiﬁc advisor to iCareAnalytics and also
has an equity share.
References
[1] H. Chen, S.S. Fuller, C. Friedman, W. Hersh, Medical Informatics: Knowledge
Management and Data Mining in Biomedicine, vol. 8, Springer Science &
Business Media, 2006.
[2] A. Belle, M.A. Kon, K. Najarian, Biomedical informatics for computer-aided
decision support systems: a survey, Sci. World J. (2013).[3] Y. Zhang, S. Fong, J. Fiaidhi, S. Mohammed, Real-time clinical decision support
system with data stream mining, BioMed. Res. Int. (2012).
[4] J.M. Hardin, D.C. Chhieng, Data mining and clinical decision support systems,
in: Clinical Decision Support Systems, Springer, 2007, pp. 44–63.
[5] P.B. Jensen, L.J. Jensen, S. Brunak, Mining electronic health records: towards
better research applications and clinical care, Nat. Rev. Genet. 13 (6) (2012)
395–405.
[6] T.-H. Cheng, C.-P. Wei, V.S. Tseng, Feature selection for medical data mining:
comparisons of expert judgment and automatic approaches, in: 19th IEEE
International Symposium on Computer-Based Medical Systems, 2006 (CBMS
2006), IEEE, 2006, pp. 165–170.
[7] H. Liu, H. Motoda, Feature Extraction, Construction and Selection: A Data
Mining Perspective, Springer Science & Business Media, 1998.
[8] T. Reinartz, A unifying view on instance selection, Data Min. Knowl. Discovery
6 (2) (2002) 191–210.
[9] I. Yoo, P. Alafaireet, M. Marinov, K. Pena-Hernandez, R. Gopidi, J.-F. Chang, L.
Hua, Data mining in healthcare and biomedicine: a survey of the literature, J.
Med. Syst. 36 (4) (2012) 2431–2448.
[10] M.A. Jabbar, B. Deekshatulu, P. Chandra, Classiﬁcation of heart disease using
artiﬁcial neural network and feature subset selection, GJCST 13 (3) (2013).
[11] D.A. Davis, N.V. Chawla, N.A. Christakis, A.-L. Barabási, Time to care: a
collaborative engine for practical disease prediction, Data Min. Knowl.
Discovery 20 (3) (2010) 388–415.
[12] E. AbuKhousa, P. Campbell, Predictive data mining to support clinical
decisions: an overview of heart disease prediction systems, in: 2012
International Conference on Innovations in Information Technology (IIT),
IEEE, 2012, pp. 267–272.
[13] P.C. Austin, J.V. Tu, J.E. Ho, D. Levy, D.S. Lee, Using methods from the data-
mining and machine-learning literature for disease classiﬁcation and
prediction: a case study examining classiﬁcation of heart failure subtypes, J.
Clin. Epidemiol. 66 (4) (2013) 398–407.
[14] T.H. McCormick, C. Rudin, D. Madigan, et al., Bayesian hierarchical rule
modeling for predicting medical conditions, Ann. Appl. Stat. 6 (2) (2012) 652–
668.
[15] J. Zhou, J. Liu, V.A. Narayan, J. Ye, A.D.N. Initiative, et al., Modeling disease
progression via multi-task learning, NeuroImage 78 (2013) 233–248.
[16] H.M. Fonteijn, M.J. Clarkson, M. Modat, J. Barnes, M. Lehmann, S. Ourselin, N.C.
Fox, D.C. Alexander, An event-based disease progression model and its
application to familial alzheimers disease, in: Information Processing in
Medical Imaging, Springer, 2011, pp. 748–759.
[17] Y. Yang, S.J. Adelstein, A.I. Kassis, Target discovery from data mining
approaches, Drug Discovery Today 17 (2012) S16–S23.
[18] D. Goldberg, D. Nichols, B.M. Oki, D. Terry, Using collaborative ﬁltering to
weave an information tapestry, Commun. ACM 35 (12) (1992) 61–70.
[19] P. Resnick, H.R. Varian, Recommender systems, Commun. ACM 40 (3) (1997)
56–58.
[20] J.S. Breese, D. Heckerman, C. Kadie, Empirical analysis of predictive algorithms
for collaborative ﬁltering, in: Proceedings of the Fourteenth Conference on
Uncertainty in Artiﬁcial Intelligence, Morgan Kaufmann Publishers Inc., 1998,
pp. 43–52.
[21] L. Duan, W.N. Street, E. Xu, Healthcare information systems: data mining
methods in the creation of a clinical recommender system, Enterprise Inform.
Syst. 5 (2) (2011) 169–181.
[22] J. Kim, D. Lee, K.-Y. Chung, Item recommendation based on context-aware
model for personalized u-healthcare service, Multimedia Tools Appl. 71 (2)
(2014) 855–872.
[23] E. Vlahu-Gjorgievska, V. Trajkovik, Personal healthcare system model using
collaborative ﬁltering techniques, Adv. Inform. Sci. Service Sci. 3 (3) (2011).
[24] N.V. Chawla, D.A. Davis, Bringing big data to personalized healthcare: a
patient-centered framework, J. General Internal Med. 28 (3) (2013) 660–665.
[25] V.N. Slee, The international classiﬁcation of diseases: ninth revision icd-9, Ann.
Internal Med. 88 (3) (1978) 424–426.
[26] Centers for Disease Control and Prevention, International classiﬁcation of
diseases – 9, abbreviated titles, 2014. <http://wonder.cdc.gov/wonder/
sci_data/codes/icd9/type_txt/icd9abb.asp>.
[27] P. Bui, D. Rajan, B. Abdul-Wahid, J. Izaguirre, D. Thain, Work queue+ python: a
framework for scalable scientiﬁc ensemble applications, in: Workshop on
Python for High Performance and Scientiﬁc Computing at SC11, 2011.
[28] S. Berkovsky, Y. Eytani, T. Kuﬂik, F. Ricci, Enhancing privacy and preserving
accuracy of a distributed collaborative ﬁltering, in: Proceedings of the 2007
ACM Conference on Recommender Systems, ACM, 2007, pp. 9–16.
[29] J. Dean, S. Ghemawat, Mapreduce: simpliﬁed data processing on large clusters,
Commun. ACM 51 (1) (2008) 107–113.
[30] G. Salton, M.J. McGill, Introduction to Modern Information Retrieval, 1983.
[31] J.H. McDonald, Handbook of Biological Statistics, vol. 2, Sparky House
Publishing, Baltimore, MD, 2009.
[32] D. Mechanic, D.D. McAlpine, M. Rosenthal, Are patients’ ofﬁce visits with
physicians getting shorter?, New England J Med. 344 (3) (2001) 198–204.
[33] A. Bachmann, J. de la Rosette, Benign Prostatic Hyperplasia and Lower Urinary
Tract Symptoms in Men, Oxford University Press, 2011.
[34] Centers for Disease Control and Prevention, National diabetes surveillance
system. <http://apps.nccd.cdc.gov/DDTSTRS/default.aspx>.
[35] A.D.A.M. Medical Encyclopedia, Hypopituitarism. <http://www.ncbi.nlm.
nih.gov/pubmedhealth/PMH0001383/>.
[36] A.D.A.M. Medical Encyclopedia, Goodpasture syndrome. <http://www.ncbi.
nlm.nih.gov/pubmedhealth/PMH0001197/>.
